newsfilter
← Latest News
PR Newswire·

NeuroSense Announces Pricing of Insider-Led PIPE Financing

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe...